Dashboard
Poor long term growth as Net Sales has grown by an annual rate of 14.19% and Operating profit at 1.41% over the last 5 years
Stock is technically in a Mildly Bearish range
With ROCE of 9.3, it has a Very Expensive valuation with a 2.6 Enterprise value to Capital Employed
Despite the size of the company, domestic mutual funds hold only 0% of the company
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Specialty Chemicals
INR 1,404 Cr (Micro Cap)
29.00
23
0.43%
0.05
9.15%
2.76
Total Returns (Price + Dividend) 
Latest dividend: 2.5 per share ex-dividend date: Jul-23-2026
Risk Adjusted Returns v/s 
Returns Beta
News

Paushak Ltd is Rated Hold by MarketsMOJO
Paushak Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 14 November 2026, providing investors with the latest insights into its performance and outlook.
Read More
Paushak Ltd is Rated Hold by MarketsMOJO
Paushak Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 04 August 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 23 October 2026, providing investors with the most recent insights into its performance and outlook.
Read More
Paushak Ltd Technical Momentum Shifts Amid Volatile Trading
Paushak Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a sharp 17.94% drop in the stock price on 21 Oct 2026, the company’s technical parameters suggest a nuanced outlook that investors should carefully analyse.
Read More Announcements 
Announcement under Regulation 30 (LODR)-Newspaper Publication
17-Oct-2026 | Source : BSEIn accordance with Regulation 30 and Regulation 47 of SEBI Listing Regulations newspaper advertisement related to Unaudited Financial Results of the Company for the quarter and half year ended on 30th September 2026.
Unaudited Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 2026.
16-Oct-2026 | Source : BSEUnaudited Financial Results of the Company.
Board Meeting Outcome for Outcome Of Board Meeting
16-Oct-2026 | Source : BSEOutcome of Board Meeting
Corporate Actions 
No Upcoming Board Meetings
Paushak Ltd has declared 50% dividend, ex-date: 23 Jul 26
Paushak Ltd has announced 5:10 stock split, ex-date: 03 Oct 25
Paushak Ltd has announced 3:1 bonus issue, ex-date: 03 Oct 25
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Sep 2026
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 6 FIIs (0.11%)
Nirayu Private Limited (41.15%)
None
22.18%
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ
QoQ Growth in quarter ended Sep 2026 is 6.91% vs 51.52% in Jun 2026
QoQ Growth in quarter ended Sep 2026 is -10.53% vs 20.70% in Jun 2026
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is 4.88% vs 8.65% in Sep 2024
Growth in half year ended Sep 2025 is -15.78% vs 9.12% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is 3.08% vs 4.03% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -32.58% vs 10.19% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'26
YoY Growth in year ended Mar 2026 is 3.63% vs 2.27% in Mar 2025
YoY Growth in year ended Mar 2026 is -20.35% vs -9.14% in Mar 2025